Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.

American journal of hematology - 1 Nov 2015

Gotlib Jason

Abstract excerpt

DISEASE OVERVIEW: The eosinophilias encompass a broad range of non-hematologic (secondary or reactive) and hematologic (primary, clonal) disorders with potential for end-organ damage. DIAGNOSIS: Hypereosinophilia has generally been defined as a peripheral blood eosinophil count greater than 1,500/mm(3) and may be associated with tissue damage. After exclusion of secondary causes of eosinophilia, diagnostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Disease Management
Share to Eosinophilia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eosinophils

Share to Hydroxyurea

Share to Receptor, Fibroblast Growth Factor, Type 1

Share to Receptor, Platelet-Derived Growth Factor alpha

Share to Receptor, Platelet-Derived Growth Factor beta

Source

Identifiers

PMID: 26486351
DOI: 10.1002/ajh.24196

Genes

CEL
PDGFRA
PDGFRB
FGFR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.PMID 26486351Read ↗

Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.Semantic proximity Read ↗

Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.Semantic proximity Read ↗

Molecular Classification and Pathogenesis of Eosinophilic Disorders: 2005 UpdateSemantic proximity Read ↗

Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapySemantic proximity Read ↗

The hypereosinophilic syndromes: current concepts and treatments.Semantic proximity Read ↗

Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia.Semantic proximity Read ↗

Management of F/P+/- hypereosinophilic syndromes: case report and treatment review.Semantic proximity Read ↗

Hypereosinophilic syndrome.Semantic proximity Read ↗

The Diagnostic Work-Up of Hypereosinophilia.Semantic proximity Read ↗

Hematological Neoplasm with EosinophiliaSemantic proximity Read ↗

The international consensus classification of eosinophilic disorders and systemic mastocytosisSemantic proximity Read ↗

Updates on eosinophilic disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.